Lee Ainslie Bausch Health Companies Inc. Transaction History
Maverick Capital LTD
- $5.07 Billion
- Q2 2024
A detailed history of Lee Ainslie (Maverick Capital LTD) transactions in Bausch Health Companies Inc. stock. As of the latest transaction made, Maverick Capital LTD holds 230,431 shares of BHC stock, worth $2.13 Million. This represents 0.03% of its overall portfolio holdings.
Number of Shares
230,431Holding current value
$2.13 Million% of portfolio
0.03%Shares
17 transactions
Others Institutions Holding BHC
# of Institutions
269Shares Held
279MCall Options Held
5.68MPut Options Held
17.4M-
Icahn Carl C Sunny Isles Beach, FL34.7MShares$322 Million2.24% of portfolio
-
John Paulson Paulson & Co. Inc. | New York, Ny26.4MShares$245 Million14.13% of portfolio
-
Goldentree Asset Management LP New York, NY22.4MShares$208 Million15.5% of portfolio
-
Nomura Holdings Inc Tokyo, M019.4MShares$179 Million0.27% of portfolio
-
National Bank Of Canada15.7MShares$145 Million0.17% of portfolio
About Bausch Health Companies Inc.
- Ticker BHC
- Exchange NYSE
- Sector Healthcare
- Industry Drug Manufacturers—Specialty & Generic
- Shares Outstandng 361,728,000
- Market Cap $3.35B
- Description
- Bausch Health Companies Inc., together with its subsidiaries, develops, manufactures, and markets a range of pharmaceutical, medical device, and over-the-counter (OTC) products primarily in the therapeutic areas of eye health, gastroenterology, and dermatology. The company operates through five segments: Bausch + Lomb, Salix, International Rx, O...